206 related articles for article (PubMed ID: 31413087)
1. IL6R-STAT3-ADAR1 (P150) interplay promotes oncogenicity in multiple myeloma with 1q21 amplification.
Teoh PJ; Chung TH; Chng PYZ; Toh SHM; Chng WJ
Haematologica; 2020 May; 105(5):1391-1404. PubMed ID: 31413087
[TBL] [Abstract][Full Text] [Related]
2. The RNA-editing enzyme ADAR1: a regulatory hub that tunes multiple dsRNA-sensing pathways.
Nakahama T; Kawahara Y
Int Immunol; 2023 Mar; 35(3):123-133. PubMed ID: 36469491
[TBL] [Abstract][Full Text] [Related]
3. Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis.
Teoh PJ; An O; Chung TH; Chooi JY; Toh SHM; Fan S; Wang W; Koh BTH; Fullwood MJ; Ooi MG; de Mel S; Soekojo CY; Chen L; Ng SB; Yang H; Chng WJ
Blood; 2018 Sep; 132(12):1304-1317. PubMed ID: 30061158
[TBL] [Abstract][Full Text] [Related]
4. Decoupling expression and editing preferences of ADAR1 p150 and p110 isoforms.
Sun T; Yu Y; Wu X; Acevedo A; Luo JD; Wang J; Schneider WM; Hurwitz B; Rosenberg BR; Chung H; Rice CM
Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33723056
[TBL] [Abstract][Full Text] [Related]
5. RNA-Editing Enzyme ADAR1 p150 Isoform Is Critical for Germinal Center B Cell Response.
Li Y; Ruan GX; Chen W; Huang H; Zhang R; Wang J; Li Y; Xu S; Ou X
J Immunol; 2022 Sep; 209(6):1071-1082. PubMed ID: 35977796
[TBL] [Abstract][Full Text] [Related]
6. The ADAR1 editome reveals drivers of editing-specificity for ADAR1-isoforms.
Kleinova R; Rajendra V; Leuchtenberger AF; Lo Giudice C; Vesely C; Kapoor U; Tanzer A; Derdak S; Picardi E; Jantsch MF
Nucleic Acids Res; 2023 May; 51(9):4191-4207. PubMed ID: 37026479
[TBL] [Abstract][Full Text] [Related]
7. The p150 Isoform of ADAR1 Blocks Sustained RLR signaling and Apoptosis during Influenza Virus Infection.
Vogel OA; Han J; Liang CY; Manicassamy S; Perez JT; Manicassamy B
PLoS Pathog; 2020 Sep; 16(9):e1008842. PubMed ID: 32898178
[TBL] [Abstract][Full Text] [Related]
8. Adenosine-Deaminase-Acting-on-RNA-1 Facilitates T-cell Migration toward Human Melanoma Cells.
Margolis N; Moalem H; Meirson T; Galore-Haskel G; Markovits E; Baruch EN; Vizel B; Yeffet A; Kanterman-Rifman J; Debby A; Besser MJ; Schachter J; Markel G
Cancer Immunol Res; 2022 Sep; 10(9):1127-1140. PubMed ID: 35731225
[TBL] [Abstract][Full Text] [Related]
9. Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma.
Lazzari E; Mondala PK; Santos ND; Miller AC; Pineda G; Jiang Q; Leu H; Ali SA; Ganesan AP; Wu CN; Costello C; Minden M; Chiaramonte R; Stewart AK; Crews LA; Jamieson CHM
Nat Commun; 2017 Dec; 8(1):1922. PubMed ID: 29203771
[TBL] [Abstract][Full Text] [Related]
10. Reovirus-mediated induction of ADAR1 (p150) minimally alters RNA editing patterns in discrete brain regions.
Hood JL; Morabito MV; Martinez CR; Gilbert JA; Ferrick EA; Ayers GD; Chappell JD; Dermody TS; Emeson RB
Mol Cell Neurosci; 2014 Jul; 61():97-109. PubMed ID: 24906008
[TBL] [Abstract][Full Text] [Related]
11. RNA editing enzyme adenosine deaminase is a restriction factor for controlling measles virus replication that also is required for embryogenesis.
Ward SV; George CX; Welch MJ; Liou LY; Hahm B; Lewicki H; de la Torre JC; Samuel CE; Oldstone MB
Proc Natl Acad Sci U S A; 2011 Jan; 108(1):331-6. PubMed ID: 21173229
[TBL] [Abstract][Full Text] [Related]
12. Deciphering the Biological Significance of ADAR1-Z-RNA Interactions.
Nakahama T; Kawahara Y
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768866
[TBL] [Abstract][Full Text] [Related]
13. Identification of ADAR1 p150 and p110 Associated Edit Sites.
Sun T; Rosenberg BR; Chung H; Rice CM
Methods Mol Biol; 2023; 2651():285-294. PubMed ID: 36892775
[TBL] [Abstract][Full Text] [Related]
14. Adenosine deaminase acting on RNA-1 (ADAR1) inhibits hepatitis B virus (HBV) replication by enhancing microRNA-122 processing.
Liu G; Ma X; Wang Z; Wakae K; Yuan Y; He Z; Yoshiyama H; Iizasa H; Zhang H; Matsuda M; Sugiyama R; Yuan Z; Muramatsu M; Li L
J Biol Chem; 2019 Sep; 294(38):14043-14054. PubMed ID: 31366735
[TBL] [Abstract][Full Text] [Related]
15. An Aicardi-Goutières Syndrome-Causative Point Mutation in
Inoue M; Nakahama T; Yamasaki R; Shibuya T; Kim JI; Todo H; Xing Y; Kato Y; Morii E; Kawahara Y
J Immunol; 2021 Dec; 207(12):3016-3027. PubMed ID: 34772697
[TBL] [Abstract][Full Text] [Related]
16. ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia.
Jiang Q; Crews LA; Barrett CL; Chun HJ; Court AC; Isquith JM; Zipeto MA; Goff DJ; Minden M; Sadarangani A; Rusert JM; Dao KH; Morris SR; Goldstein LS; Marra MA; Frazer KA; Jamieson CH
Proc Natl Acad Sci U S A; 2013 Jan; 110(3):1041-6. PubMed ID: 23275297
[TBL] [Abstract][Full Text] [Related]
17. Isoforms of RNA-Editing Enzyme ADAR1 Independently Control Nucleic Acid Sensor MDA5-Driven Autoimmunity and Multi-organ Development.
Pestal K; Funk CC; Snyder JM; Price ND; Treuting PM; Stetson DB
Immunity; 2015 Nov; 43(5):933-44. PubMed ID: 26588779
[TBL] [Abstract][Full Text] [Related]
18. Double-stranded RNA deaminase ADAR1 promotes the Zika virus replication by inhibiting the activation of protein kinase PKR.
Zhou S; Yang C; Zhao F; Huang Y; Lin Y; Huang C; Ma X; Du J; Wang Y; Long G; He J; Liu C; Zhang P
J Biol Chem; 2019 Nov; 294(48):18168-18180. PubMed ID: 31636123
[TBL] [Abstract][Full Text] [Related]
19. RNA-specific adenosine deaminase ADAR1 suppresses measles virus-induced apoptosis and activation of protein kinase PKR.
Toth AM; Li Z; Cattaneo R; Samuel CE
J Biol Chem; 2009 Oct; 284(43):29350-6. PubMed ID: 19710021
[TBL] [Abstract][Full Text] [Related]
20. [Expression of ADAR1 isoforms in murine acute T-ALL leukemia model].
Ma CH; Tian C; Chong JH; Shi YX; Wang JH; Lin YM; Xu J; Zheng GG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):566-9. PubMed ID: 21729523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
